What does a radioactive thyroid scan showing areas of both increased and suppressed uptake indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Radioactive Thyroid Scan with Mixed Increased and Suppressed Uptake

A radioactive thyroid scan showing both areas of increased uptake and suppressed uptake is pathognomonic for toxic multinodular goiter, where autonomous hyperfunctioning nodules ("hot" nodules) suppress the surrounding normal thyroid tissue. 1

Pattern Recognition and Diagnosis

The characteristic pattern you describe represents:

  • Multiple "hot" areas (increased uptake) corresponding to autonomous hyperfunctioning nodules that are producing excess thyroid hormone independently of TSH control 1, 2
  • Intervening "cold" areas (suppressed uptake) representing normal thyroid tissue that has been suppressed by the autonomous nodules through negative feedback on TSH 1, 3

This heterogeneous pattern with multiple areas of variable activity distributed throughout the gland is diagnostic of toxic multinodular goiter when TSH is suppressed 3, 2. The autonomous nodules function independently due to somatic activating gain-of-function mutations in the TSH receptor 2.

Differential Diagnosis Considerations

While toxic multinodular goiter is the most common cause of this pattern, other rare scenarios can produce mixed uptake:

  • Marine-Lenhart syndrome: Coexistence of Graves' disease with an autonomously functioning nodule, showing diffuse uptake throughout the gland with superimposed focal increased uptake in the autonomous nodule 4
  • Non-toxic multinodular goiter (euthyroid state): Shows heterogeneous uptake with variable activity but without suppression of intervening tissue, as TSH is not suppressed 3

The key distinguishing feature is the biochemical context: toxic multinodular goiter presents with suppressed TSH, elevated free T4/T3, and negative TSH receptor antibodies (ruling out Graves' disease) 1, 2.

Clinical Implications for Management

Definitive treatment planning should prioritize thyroidectomy as the preferred approach in younger patients or those with compressive symptoms, as it provides immediate cure and rapid restoration of normal thyroid function. 1

Alternative treatment options include:

  • Radioactive iodine therapy: The scan pattern helps calculate the appropriate dose based on the volume of hyperfunctioning tissue; the goal is to achieve euthyroid status (not hypothyroidism as in Graves' disease) 3, 2
  • Antithyroid medications: Typically used as a bridge to definitive therapy rather than long-term management 2

Important Caveats

  • The scan has low positive predictive value for malignancy and cannot determine which nodules require biopsy 3. Any suspicious nodules on ultrasound should still undergo fine-needle aspiration regardless of their uptake pattern 3.
  • Coexisting thyroid cancer can be missed if ultrasound evaluation is skipped and only scintigraphy is performed 3. Always perform ultrasound first in the diagnostic algorithm, even when TSH is suppressed 3.
  • The pattern can evolve with treatment: autonomous nodules may change from "hot" to "cool" during antithyroid drug therapy as TSH levels normalize 4.

References

Guideline

Toxic Multinodular Goiter

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021

Guideline

Thyroid Imaging Selection Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the next step in managing a patient with a low Thyroid-Stimulating Hormone (TSH) level, normal Triiodothyronine (T3) and Thyroxine (T4) levels, and a radioactive iodine uptake scan showing multiple areas of increased and suppressed uptake?
How to manage an elderly female with hyperthyroidism and musculoskeletal symptoms without evidence of rheumatoid arthritis?
What is the most likely diagnosis for a patient presenting with diaphoresis, palpitations, an enlarged neck with discomfort, and hypothyroid-stimulating hormone (TSH) level?
What is the pathophysiology, clinical presentation, diagnosis, and treatment of hyperthyroidism?
What is the most likely outcome of thyroid scintigraphy and radioactive iodine uptake (RAIU) scan in a patient with symptoms of hyperthyroidism, such as heat intolerance, palpitations, and tremor, and laboratory results showing low Thyroid-Stimulating Hormone (TSH) and high Thyroxine (T4) levels?
What are the risks of adding low-dose Adderall (amphetamine and dextroamphetamine) extended release to a regimen that includes Rexulti (brexpiprazole) and Effexor (venlafaxine)?
What is the recommended treatment regimen for aspiration pneumonia using IV cefepime, Flagyl (metronidazole) and vancomycin?
What is the management of diarrhea in pregnant women?
What are the signs, symptoms, diagnosis, and treatment of pneumonia?
What is the treatment for ocular herpes?
Is further surgical intervention, including reinsertion of spinal fixation device, arthrodesis, laminectomy, and foraminotomy, medically indicated for a patient with chronic lower back pain and a history of previous spinal fusion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.